Over a week ago
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
$44.16 / -10.225 (-18.80%)
02/28/22 Yeti announces $100M share buyback 02/17/22 Yeti winding down relationship with Lowe's, doesn't see 'any material impact' 07/29/22 Walmart announces launch of 'Walmart Restored' refurbished sales program 07/28/22 Walmart to open new general stores at Getaway outposts 07/26/22 Walmart partner with WALDO to offer affordable contact lenses 07/25/22 Walmart down 6% after lowering profit outlook for Q2, FY23 08/04/22 Visa, RevoluPAY enter agreement for affiliate membership 07/28/22 Bread Financial, AAA sign multi-year agreement 07/26/22 Visa reports Q3 payments volume up 12% y/y 07/14/22 Verizon Visa Card holders can earn 4% rewards on gas purchases 08/03/22 Under Armour sees 'overabundance' of product hitting the market in 2022 08/03/22 Under Armour's Plank says Browne in running for permanent CEO job 08/03/22 Under Armour's Plank: Interim CEO Colin Browne has done 'outstanding' job 08/03/22 Under Armour focused on search for permanent CEO, says Plank 07/06/22 Trupanion announces availability of direct payment solutions 06/29/22 Eco Material Technologies announces agreement with Georgia Power 06/29/22 Georgia Power to launch landmark coal ash beneficial use project 04/19/22 Southern Company raises annual dividend by 8c per share to $2.72 per share 03/18/22 U.S. district court gives preliminary approval of Southern Company settlement 08/04/22 Siga, Chimerix rallyafter WaPo report of monkeypox emergency declaration 07/29/22 FDA provides update on agency response to monkeypox outbreak 07/29/22 Siga Technologies trading resumes 07/29/22 Siga Technologies trading halted, volatility trading pause 08/04/22 Lordstown reaffirms Q3 target to Endurance commercial production 07/12/22 Lordstown Motors says Edward Hightower elected to additional role of CEO 07/12/22 Lordstown Motors says Edward Hightower elected to additional role of CEO 05/19/22 Lordstown Motors names Daniel Ninivaggi as Chairman of the Board 07/25/22 Tim China announces collaboration with Easy Joy 07/25/22 Kitchen United announces $100M Series C fundraise 05/16/22 Pershing Square boosts Canadian Pacific, cuts Domino's in Q1 05/05/22 Regis names Matthew Doctor as CEO 08/04/22 Paymentus falls -23.9% 08/04/22 Paymentus falls -19.7% 02/18/22 Paymentus falls -12.1% 02/17/22 Paymentus falls -20.4% 07/25/22 NFL launches exclusive streaming subscription service NFL+ 06/21/22 Paramount+ intends to commission 150 international originals by 2025 06/13/22 AMC says past weekend admissions revenues 15% higher than same period in 2019 08/04/22 Paramount says seeing weakness in macro advertising market 08/04/22 Paramount says direct to consumer losses will be greatest in 2023 08/04/22 Paramount says 'clearly navigating some near term headwinds' 08/03/22 Paramount+ to launch as a Premium Subscription within Roku Channel 07/21/22 Pacific Biosciences names Jeff Eidel as Chief Commercial Officer 06/30/22 Pacific Biosciences, Invitae amend development and commercialization agreement 04/21/22 Pacific Bioscience releases new update to its HiFi sequencing technology 04/21/22 Pacific Biosciences, Children's Mercy Kansas City expand collaboration 08/04/22 Eli Lilly ordered to pay $61M for Medicaid fraud, law firm says 07/18/22 Erasca announces trial collaboration, supply agreement with Eli Lilly 07/10/22 Fly Intel: Top five weekend stock stories 06/29/22 AbCellera says Lilly to supply U.S. with added 150,000 bebtelovimab doses 07/28/22 Kohl's becomes 'exclusive' wholesale retailer for Levi's SilverTab collection 07/07/22 Levi Strauss raises quarterly dividend 20% to 12c per share 06/01/22 Levi Strauss trading resumes 06/01/22 Levi Strauss approves $750M share repurchase authorization 08/04/22 Kellogg: Gross profit dollars remain on upward trajectory 08/04/22 Kellogg: North America Cereal, Plant Co. to be stronger as separate companies 08/04/22 Kellogg: Q2 was 'exceptional' in North America 08/04/22 Kellogg raises FY22 organic-basis sales growth to 7%-8% from 4% 08/01/22 Intel outlook changed to negative at Moody's on challenges 07/29/22 Intel winding down Optane memory business, says CEO Gelsinger 07/28/22 Intel falls over 8% to $36.39 after Q2 earnings miss and FY22 guidance cut 07/28/22 Intel reiterates FY adjusted free cash flow guidance 06/13/22 Gannett announces Vincent Cirel as CTO 06/01/22 Gannett restructuring into two distinct business units 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 03/09/22 Gannett responds to WSJ article regarding inaccurate information to advertisers GBT Global Blood Therapeutics $47.99 / +14.075 (+41.50%)
08/04/22 Global Blood Therapeutics jumps 40% after report of takeover interest 07/26/22 Global Blood Therapeutics gets marketing authorization for Oxbryta from MHRA 07/14/22 Global Blood Therapeutics initiates EAP for voxelotor in Brazil 07/13/22 The GBT Foundation awards $250,000 in ACE Grants 04/29/22 Ecovyst falls -12.5% 04/28/22 Ecovyst authorizes up to $450M share repurchase program 04/28/22 Ecovyst names Kurt Bitting CEO, Kevin Fogarty chairman 03/23/22 Axalta Coating appoints Evans as VP, Investor Relations 08/04/22 Coinbase trading resumes 08/04/22 Coinbase trading halted, volatility trading pause 08/04/22 Coinbase jumps 34% to $108.46 after announcing partnership with BlackRock 08/04/22 Coinbase selected by BlackRock for crypto trading access 06/24/22 Chimerix announces $25.3M TEMBEXA procurement agreement 06/23/22 Chimerix announces $9.3M TEMBEXA procurement agreement 05/16/22 Chimerix terminates DSTAT development program, focuses on imipridone platform 06/16/22 Cigna announces $3.5B accelerated stock repurchase agreements 06/07/22 FTC announces inquiry into pharmacy benefit managers 05/02/22 Bioventus agrees to nationwide contract with Cigna for DUROLANE, GELSYN-3 03/08/22 Kala Pharmaceuticals announces EYSUVIS now covered by UnitedHealthcare, Cigna $50.34 / +26.24 (+108.88%)
07/05/22 ChemoCentryx appoints Jennifer Herron to board of directors 06/06/22 ChemoCentryx reports safety results from Phase 1 trial of CCX559 $19.15 / +0.8755 (+4.79%)
07/27/22 Bavarian Nordic receives approvals to finish vaccine manufacturing facility 07/25/22 Bavarian Nordic receives European approval of Imvanex to include monkeypox 07/15/22 Bavarian Nordic receives order for monkeypox vaccines from U.S. Government 07/18/22 BlackRock, QLS Advisors announce partnership 07/15/22 BlackRock reports Q2 total net inflows of $90B 08/04/22 BioCryst resumes enrollment in BCX9930 clinical program 08/04/22 BioCryst sees 2022 ORLADEYO revenue $255M-$265M 07/01/22 BioCryst presents new data on ORLADEYO 06/22/22 BioCryst announces ORLADEYO data to be presented at EEACI Hybrid Congress 2022 08/04/22 Alibaba CEO says 'we saw signs of recovery across our businesses in June' 07/29/22 SEC adds Alibaba, Mogo to list of companies facing possible delisting 07/29/22 SEC adds Alibaba to Holding Foreign Companies Accountable Act list 07/25/22 Alibaba pursues primary listing in Hong Kong 08/04/22 Altice USA rises 14.6% 08/04/22 Altice USA confirms inquiries for Suddenlink assets in earnings call 08/03/22 Altice USA backs FY22 capex view of $1.7B-$1.8B 07/21/22 Altice USA trading resumes, shares jump 27% to $11.65 after Bloomberg report 08/04/22 Amgen to acquire ChemoCentryx for $52 per share in cash, or EV of $3.7B 08/04/22 Amgen to acquire ChemoCentryx for $52 per share in cash 07/27/22 Ideaya Biosciences, Amgen enter IDE397 clinical trial collaboration 06/06/22 Amgen announces FDA approved RIABNI 08/04/22 Baird Alibaba price target raised to $140 from $134 at Baird 08/01/22 BofA Alibaba price target lowered to $155 from $162 at BofA 07/19/22 Bernstein Alibaba upgraded to Outperform from Market Perform at Bernstein 07/11/22 Goldman Sachs Pinduoduo grocery focus to drive sustained growth, says Goldman Sachs 08/05/22 Citi Citi cuts Coinbase target but opens 'upside Catalyst Watch' 08/04/22 JMP Securities JMP 'encouraged' by Coinbase partnership with BlackRock's Aladdin 08/04/22 Mizuho Coinbase shares jumped 20% 'for no good reason,' says Mizuho 07/25/22 JPMorgan JPMorgan sees increased share dilution risk for Coinbase, Robinhood 05/20/22 Benchmark Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare 05/16/22 H.C. Wainwright Chimerix price target lowered to $11 from $24 at H.C. Wainwright 12/22/21 H.C. Wainwright Chimerix price target raised to $24 from $21 at H.C. Wainwright 11/22/21 H.C. Wainwright Chimerix price target raised to $21 from $19 at H.C. Wainwright $19.15 / +0.8755 (+4.79%)
07/20/22 Cowen Bavarian Nordic upgraded to Outperform from Market Perform at Cowen 02/04/22 Cowen Bavarian Nordic downgraded to Market Perform from Outperform at Cowen 12/22/21 Kempen Bavarian Nordic downgraded to Neutral from Buy at Kempen 07/18/22 Deutsche Bank BlackRock price target lowered to $720 from $725 at Deutsche Bank 07/13/22 Deutsche Bank BlackRock price target lowered to $725 from $747 at Deutsche Bank 07/11/22 UBS BlackRock price target lowered to $718 from $825 at UBS 08/05/22 RBC Capital Amgen price target raised to $236 from $224 at RBC Capital 08/05/22 Piper Sandler Amgen price target raised to $265 from $260 at Piper Sandler 08/04/22 Raymond James ChemoCentryx downgraded to Market Perform from Strong Buy at Raymond James 08/04/22 Piper Sandler ChemoCentryx downgraded to Neutral from Overweight at Piper Sandler $50.34 / +26.24 (+108.88%)
08/05/22 SVB Securities ChemoCentryx downgraded to Market Perform from Outperform at SVB Securities 08/05/22 H.C. Wainwright ChemoCentryx downgraded to Neutral from Buy at H.C. Wainwright 08/05/22 Canaccord ChemoCentryx downgraded to Hold from Buy at Canaccord 08/01/22 Jefferies Concert Pharmaceuticals price target raised to $14 from $9.50 at Jefferies 07/27/22 Benchmark AbCellera collaboration lowers reliance on Lilly, says Benchmark 07/18/22 Cowen Cowen believes Global Pharma quarterly results will be strong 07/08/22 Morgan Stanley Eli Lilly price target raised to $395 from $369 at Morgan Stanley 08/04/22 Morgan Stanley Levi Strauss downgraded to Equal Weight from Overweight at Morgan Stanley 07/20/22 Stifel Levi Strauss price target lowered to $23 from $26 at Stifel 07/15/22 UBS Levi Strauss price target lowered to $24 from $31 at UBS 07/10/22 Morgan Stanley Levi Strauss price target lowered to $19 from $33 at Morgan Stanley 08/04/22 Canaccord Trupanion price target lowered to $90 from $100 at Canaccord 08/04/22 Northland Trupanion price target lowered to $70 from $80 at Northland 08/04/22 Piper Sandler Trupanion downgraded to Neutral from Overweight at Piper Sandler 05/27/22 Piper Sandler Trupanion price target lowered to $80 from $95 at Piper Sandler 08/04/22 Williams Trading Under Armour downgraded to Sell from Hold at Williams Trading 08/04/22 Barclays Under Armour price target lowered to $12 from $14 at Barclays 08/04/22 Baird Under Armour downgraded to Neutral at Baird amid uncertain macro environment 08/04/22 Baird Under Armour downgraded to Neutral from Outperform at Baird 08/04/22 UBS Southern Company upgraded to Buy from Neutral at UBS 07/21/22 Guggenheim Southern Company price target raised to $80 from $76 at Guggenheim 07/18/22 Barclays Southern Company price target lowered to $79 from $82 at Barclays 06/30/22 UBS Southern Company price target lowered to $76 from $83 at UBS 08/04/22 Goldman Sachs Paymentus downgraded to Neutral from Buy at Goldman Sachs 07/15/22 Baird Paymentus price target lowered to $20 from $26 at Baird 05/05/22 Citi Paymentus price target lowered to $25 from $35 at Citi 05/05/22 SMBC Nikko Paymentus price target lowered to $23 from $37 at SMBC Nikko GBT Global Blood Therapeutics $47.99 / +14.075 (+41.50%)
08/04/22 Truist Truist sees Novartis, Vertex as logical suitors for Global Blood 06/28/22 JPMorgan Global Blood Therapeutics price target lowered to $36 from $39 at JPMorgan 05/11/22 Wedbush Global Blood Therapeutics added to Best Ideas List at Wedbush 05/05/22 Oppenheimer Global Blood Therapeutics price target lowered to $71 from $86 at Oppenheimer 07/29/22 BofA Amazon price target bumped to $170 at BofA after 'mostly positive' quarter 07/28/22 DA Davidson Best Buy price target lowered to $88 from $110 at DA Davidson 07/28/22 Wells Fargo Best Buy price target lowered to $70 from $82 at Wells Fargo 07/27/22 Deutsche Bank Walmart price target lowered to $142 from $166 at Deutsche Bank 08/04/22 TD Securities Altice USA price target raised to $21 from $17 at TD Securities 08/04/22 RBC Capital Altice USA price target lowered to $19 from $23 at RBC Capital 08/04/22 Pivotal Research Altice target would move to $30-$35 with Suddenlink sale, says Pivotal Research 07/22/22 New Street Altice USA upgraded to Buy from Neutral at New Street 08/03/22 Northland AMD price target raised to $105 from $95 at Northland 08/02/22 DZ Bank Intel downgraded to Sell from Hold at DZ Bank 08/01/22 Northland Intel shares 'trading below a breakup valuation,' says Northland 07/29/22 Northland Intel price target lowered to $55 from $62 at Northland 08/03/22 Truist PayPal price target raised to $108 from $80 at Truist 08/01/22 BMO Capital MasterCard price target raised to $422 from $402 at BMO Capital 07/29/22 Mizuho Visa price target raised to $220 from $215 at Mizuho 07/28/22 Susquehanna Visa price target lowered to $260 from $290 at Susquehanna 08/05/22 Oppenheimer BioCryst downgraded to Perform from Outperform at Oppenheimer 08/05/22 Barclays BioCryst price target raised to $14 from $12 at Barclays 08/04/22 Evercore ISI BioCryst downgraded to In Line from Outperform at Evercore ISI 05/05/22 Piper Sandler BioCryst price target lowered to $19 from $24 at Piper Sandler 05/10/22 R.F. Lafferty Lordstown Motors downgraded to Sell from Hold at R.F. Lafferty 05/10/22 Deutsche Bank Lordstown Motors price target lowered to $2 from $3 at Deutsche Bank 03/01/22 R.F. Lafferty Lordstown Motors price target lowered to $4 from $7 at R.F. Lafferty 03/01/22 Deutsche Bank Lordstown Motors price target lowered to $3 from $7 at Deutsche Bank 08/04/22 Canaccord Pacific Biosciences price target lowered to $14 from $17 at Canaccord 05/15/22 Piper Sandler Pacific Biosciences price target lowered to $6 from $13 at Piper Sandler 05/05/22 Cantor Fitzgerald Pacific Biosciences price target lowered to $19 from $23 at Cantor Fitzgerald 03/01/22 Piper Sandler Pacific Biosciences price target lowered to $13 from $20 at Piper Sandler 07/07/22 Citi Gannett price target lowered to $2.65 from $4.25 at Citi 06/15/22 CL King Ecovys, Innospec to benefit after EPA raises RFS to 15%, says CL King 03/23/22 BWS Financial Ecovyst initiated with a Buy at BWS Financial 03/02/22 Deutsche Bank Ecovyst price target lowered to $13 from $16 at Deutsche Bank 11/29/21 Citi Ecovyst initiated with a Neutral at Citi 08/04/22 Piper Sandler Kellogg upgraded to Neutral from Underweight at Piper Sandler 07/07/22 UBS Kellogg downgraded to Neutral from Buy at UBS 06/22/22 JPMorgan Kellogg breakup likely doesn't alter share valuation, says JPMorgan 06/22/22 Deutsche Bank Kellogg price target lowered to $72 from $74 at Deutsche Bank 08/05/22 JPMorgan JPMorgan downgrades Paramount to Underweight on soft DTC revenue 08/05/22 Morgan Stanley Paramount price target lowered to $20 from $22 at Morgan Stanley 08/05/22 JPMorgan Paramount downgraded to Underweight from Neutral at JPMorgan 08/02/22 Deutsche Bank Paramount price target lowered to $35 from $43 at Deutsche Bank $44.16 / -10.225 (-18.80%)
08/05/22 Credit Suisse Yeti price target lowered to $70 from $80 at Credit Suisse 08/05/22 Raymond James Yeti price target lowered to $54 from $73 at Raymond James 08/05/22 Piper Sandler Yeti price target lowered to $76 from $89 at Piper Sandler 08/05/22 Citi Yeti price target lowered to $57 from $65 at Citi 08/05/22 Mizuho Cigna price target raised to $330 from $291 at Mizuho 08/05/22 RBC Capital Cigna price target raised to $294 from $272 at RBC Capital 07/14/22 Jefferies Jefferies downgrades Cigna to Hold, views as most vulnerable MCO in downturn 07/14/22 Truist Cigna price target raised to $330 from $310 at Truist 08/05/22 Baird Restaurant Brands price target raised to $63 from $56 at Baird 08/05/22 Deutsche Bank Restaurant Brands price target raised to $70 from $64 at Deutsche Bank 07/18/22 Morgan Stanley Restaurant Brands price target lowered to $52 from $56 at Morgan Stanley 07/11/22 Deutsche Bank Restaurant Brands price target lowered to $64 from $70 at Deutsche Bank $44.16 / -10.225 (-18.80%)
08/04/22 Yeti reports Q2 adjusted EPS 63c vs. 68c a year ago 05/11/22 Yeti raises FY22 adjusted EPS view to $2.86-$2.91 from $2.82-$2.86 07/25/22 Walmart lowers profit outlook for FY23, sees adjusted EPS to decline 10%-12% 07/25/22 Walmart lowers profit outlook for Q2, sees adjusted EPS to decline 8%-9% 07/25/22 Walmart lowers profit outlook for Q2 and FY23 05/17/22 Walmart cuts FY23 EPS view to flat from up 5%-6%, consensus $6.76 07/26/22 Visa reports Q3 EPS $1.98, consensus $1.74 07/26/22 Notable companies reporting after market close 04/26/22 Visa reports Q2 EPS $1.79, consensus $1.65 04/26/22 Notable companies reporting after market close 08/03/22 Under Armour sees Q2 EPS 15c-17c, consensus 26c 08/03/22 Under Armour lowers 2022 adjusted EPS view 47c-53c from 63c-68c 08/03/22 Under Armour reports Q1 adjusted EPS 3c, consensus 4c 08/02/22 Notable companies reporting before tomorrow's open 08/03/22 Trupanion reports Q2 EPS (33c), consensus (22c) 04/28/22 Trupanion reports Q1 EPS (22c), consensus (17c) 02/16/22 Trupanion reports Q4 EPS (17c), may not compare to consensus (95c) 07/28/22 Southern Company reports Q2 adjusted EPS $1.07, consensus 83c 04/28/22 Southern Company sees FY22 adjusted EPS $3.50-$3.60, consensus $3.55 04/28/22 Southern Company sees Q2 adjusted EPS 80c, consensus 83c 04/28/22 Southern Company reports Q1 adjusted EPS 97c, consensus 91c 03/03/22 Siga Technologies reports Q 4EPS 98c versus 26c last year 08/04/22 Lordstown Motors reports Q2 EPS 32c, consensus (45c) 05/09/22 Lordstown Motors reports Q1 EPS (46c), consensus (46c) 08/04/22 Restaurant Brands reports Q2 EPS 76c, consensus 73c 05/03/22 Restaurant Brands reports Q1 adjusted EPS 64c, consensus 62c 02/15/22 Restaurant Brands reports Q4 EPS 74c, consensus 69c 02/14/22 Notable companies reporting before tomorrow's open 08/03/22 Paymentus sees FY22 revenue $485M-$492M, consensus $495.05M 08/03/22 Paymentus reports Q2 adjusted EPS 0c, consensus 1c 05/04/22 Paymentus sees FY22 revenue $492M-$497M, consensus $492.91M 05/04/22 Paymentus reports Q1 adjusted EPS 3c, consensus 1c 08/04/22 Paramount reports Q2 EPS 53c, consensus 62c 05/03/22 Paramount reports Q1 EPS 60c, consensus 51c 08/03/22 Pacific Biosciences now sees 2022 revenue $138M-$145M, consensus $161.95M 08/03/22 Pacific Biosciences reports Q2 non-GAAP EPS (34c), consensus (32c) 05/04/22 Pacific Biosciences reports Q1 EPS (37c), consensus (31c) 02/15/22 Pacific Biosciences reports Q4 EPS (30c), consensus (28c) 08/04/22 Eli Lilly cuts FY22 EPS view to $7.90-$8.05 from $8.15-$8.30, consensus $8.08 08/04/22 Eli Lilly reports Q2 EPS $1.25, consensus $1.68 07/07/22 Levi Strauss backs FY22 adjusted EPS view $1.50-$1.56, consensus $1.55 07/07/22 Levi Strauss reports Q2 adjusted EPS 29c, consensus 23c 06/01/22 Levi Strauss says 6%-8% annual net revenue growth target up from 4%-6% view 06/01/22 Levi Strauss backs FY22 adjusted EPS view of $1.50-$1.56, consensus $1.55 08/04/22 Kellogg raises FY22 EPS growth to 2% from 1%-2%, consensus $4.10 08/04/22 Kellogg reports Q2 EPS $1.23, consensus $1.05 07/28/22 Intel cuts FY22 adjusted EPS view to $2.30, consensus $3.42 07/28/22 Intel sees Q3 adjusted EPS 35c, consensus 87c 07/28/22 Intel cuts FY revenue view to $65B-$68B, consensus $74.34B 07/28/22 Intel reports Q2 adjusted EPS 29c, consensus 69c 08/04/22 Gannett reports 'challenging' Q2 results, cuts FY22 outlook 02/24/22 Gannett sees 2022 revenue $3.07B-$3.16B, consensus $3.11B 02/24/22 Gannett sees Q1 revenue $745M-$755M 02/24/22 Gannett reports Q4 EPS (17c), one estimate (1c) GBT Global Blood Therapeutics $47.99 / +14.075 (+41.50%)
05/04/22 Global Blood Therapeutics reports Q1 EPS ($1.26), consensus ($1.30) 02/24/22 Global Blood Therapeutics reports Q4 EPS ($1.36), consensus ($1.13) 07/29/22 Ecovyst raises FY22 revenue view to $830M-$850M from $810M-$830M 07/29/22 Ecovyst reports Q2 adjusted EPS 22c, consensus 18c 04/28/22 Ecovyst sees FY22 revenue $810M-$830M, consensus $738.89M 04/28/22 Ecovyst reports Q1 adjusted EPS 15c, consensus 14c 05/10/22 Coinbase reports Q1 EPS ($1.98) vs. $3.80 last year 05/10/22 Coinbase reports Q1 revenue $1.165B, consensus $1.48B 05/10/22 Notable companies reporting after market close 02/24/22 Coinbase reports Q4 adjusted EBITDA $1.21B vs. $288M y/y 05/16/22 Chimerix reports Q1 EPS (28c), consensus (33c) 03/01/22 Chimerix reports Q4 EPS (45c), consensus (17c) 08/04/22 Cigna raises FY22 adjusted EPS view to at least $22.90 from at least $22.60 08/04/22 Cigna reports Q2 adjusted EPS $6.22, consensus $5.48 $50.34 / +26.24 (+108.88%)
05/05/22 ChemoCentryx reports Q1 EPS (55c), consensus (30c) 03/01/22 ChemoCentryx reports Q4 EPS (58c), consensus (58c) 07/15/22 BlackRock reports Q2 adjusted EPS $7.36, consensus $7.90 07/14/22 Notable companies reporting before tomorrow's open 06/20/22 Fly Intel: Top five weekend stock stories 04/13/22 BlackRock reports Q1 adjusted EPS $9.52, consensus $8.84 08/04/22 BioCryst reports Q2 EPS (32c), consensus (34c) 05/05/22 BioCryst continues to see 2022 ORLADEYO revenue no less than $250M 05/05/22 BioCryst reports Q1 EPS (40c), consensus (37c) 02/23/22 BioCryst reports Q4 adjusted EPS (40c), consensus (30c) 08/04/22 Alibaba reports Q1 adjusted EPS $1.75, consensus $1.53 08/03/22 Notable companies reporting before tomorrow's open 05/26/22 Alibaba reports Q4 EPS $1.25, consensus $1.10 08/03/22 Altice USA reports Q2 EPS 23c, consensus 32c 08/03/22 Notable companies reporting after market close 04/28/22 Altice USA reports Q1 EPS 43c, consensus 32c 04/28/22 Notable companies reporting after market close 08/04/22 Amgen backs FY22 adjusted EPS view $17.00-$18.00, consensus $17.40 08/04/22 Amgen reports Q2 adjusted EPS $4.65, consensus $4.40 08/04/22 Notable companies reporting after market close 04/27/22 Amgen backs FY22 adjusted EPS view $17.00-$18.00, consensus $17.63
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
02/28/22 Yeti announces $100M share buyback 02/17/22 Yeti winding down relationship with Lowe's, doesn't see 'any material impact' 07/29/22 Walmart announces launch of 'Walmart Restored' refurbished sales program 07/28/22 Walmart to open new general stores at Getaway outposts 07/26/22 Walmart partner with WALDO to offer affordable contact lenses 07/25/22 Walmart down 6% after lowering profit outlook for Q2, FY23 08/03/22 Under Armour sees 'overabundance' of product hitting the market in 2022 08/03/22 Under Armour's Plank says Browne in running for permanent CEO job 08/03/22 Under Armour's Plank: Interim CEO Colin Browne has done 'outstanding' job 08/03/22 Under Armour focused on search for permanent CEO, says Plank 07/06/22 Trupanion announces availability of direct payment solutions 08/02/22 U.S. video game consumer spending fell 13% y/y in Q2, says NPD 08/02/22 Logitech G, Tencent announce handheld cloud gaming partnership 07/20/22 'Minecraft' developer says NFTs, blockchain tech not allowed in the game 07/15/22 Bandai Namco's 'Elden Ring' best selling game in U.S. in June, says NPD 06/29/22 Eco Material Technologies announces agreement with Georgia Power 06/29/22 Georgia Power to launch landmark coal ash beneficial use project 04/19/22 Southern Company raises annual dividend by 8c per share to $2.72 per share 03/18/22 U.S. district court gives preliminary approval of Southern Company settlement 08/04/22 Lordstown reaffirms Q3 target to Endurance commercial production 07/12/22 Lordstown Motors says Edward Hightower elected to additional role of CEO 07/12/22 Lordstown Motors says Edward Hightower elected to additional role of CEO 05/19/22 Lordstown Motors names Daniel Ninivaggi as Chairman of the Board 07/25/22 Tim China announces collaboration with Easy Joy 07/25/22 Kitchen United announces $100M Series C fundraise 05/16/22 Pershing Square boosts Canadian Pacific, cuts Domino's in Q1 05/05/22 Regis names Matthew Doctor as CEO 08/04/22 Paymentus falls -23.9% 08/04/22 Paymentus falls -19.7% 02/18/22 Paymentus falls -12.1% 02/17/22 Paymentus falls -20.4% 07/25/22 NFL launches exclusive streaming subscription service NFL+ 06/21/22 Paramount+ intends to commission 150 international originals by 2025 06/13/22 AMC says past weekend admissions revenues 15% higher than same period in 2019 08/04/22 Paramount says seeing weakness in macro advertising market 08/04/22 Paramount says direct to consumer losses will be greatest in 2023 08/04/22 Paramount says 'clearly navigating some near term headwinds' 08/03/22 Paramount+ to launch as a Premium Subscription within Roku Channel 07/21/22 Pacific Biosciences names Jeff Eidel as Chief Commercial Officer 06/30/22 Pacific Biosciences, Invitae amend development and commercialization agreement 04/21/22 Pacific Bioscience releases new update to its HiFi sequencing technology 04/21/22 Pacific Biosciences, Children's Mercy Kansas City expand collaboration 07/26/22 Ondas' American Robotics adds AI anomaly detection capabilities to Scout System 07/20/22 Ondas' American Robotics adds capabilities to Scout System drone 07/05/22 Ondas signs term sheet to acquire Airobotics 07/05/22 Ondas to acquire Airobotics 07/18/22 Erasca announces trial collaboration, supply agreement with Eli Lilly 07/10/22 Fly Intel: Top five weekend stock stories 06/29/22 AbCellera says Lilly to supply U.S. with added 150,000 bebtelovimab doses 06/29/22 Eli Lilly to supply additional 150,000 doses of bebtelovimab to U.S. for $275M 07/28/22 Kohl's becomes 'exclusive' wholesale retailer for Levi's SilverTab collection 07/07/22 Levi Strauss raises quarterly dividend 20% to 12c per share 06/01/22 Levi Strauss trading resumes 06/01/22 Levi Strauss approves $750M share repurchase authorization 08/04/22 Kellogg: Gross profit dollars remain on upward trajectory 08/04/22 Kellogg: North America Cereal, Plant Co. to be stronger as separate companies 08/04/22 Kellogg: Q2 was 'exceptional' in North America 08/04/22 Kellogg raises FY22 organic-basis sales growth to 7%-8% from 4% 07/28/22 Google updates Play Store policies around intrusive advertisements 08/02/22 Mandiant to not provide guidance due to pending transaction with Google 08/02/22 Thryv and Google team to streamline communication for small businesses 07/31/22 Fly Intel: Top five weekend stock stories 07/29/22 Google says Stadia game streaming service not shutting down 06/13/22 Gannett announces Vincent Cirel as CTO 06/01/22 Gannett restructuring into two distinct business units 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 03/09/22 Gannett responds to WSJ article regarding inaccurate information to advertisers GBT Global Blood Therapeutics $45.62 / +11.705 (+34.51%)
08/04/22 Global Blood Therapeutics jumps 40% after report of takeover interest 07/26/22 Global Blood Therapeutics gets marketing authorization for Oxbryta from MHRA 07/14/22 Global Blood Therapeutics initiates EAP for voxelotor in Brazil 07/13/22 The GBT Foundation awards $250,000 in ACE Grants 04/29/22 Ecovyst falls -12.5% 04/28/22 Ecovyst authorizes up to $450M share repurchase program 04/28/22 Ecovyst names Kurt Bitting CEO, Kevin Fogarty chairman 03/23/22 Axalta Coating appoints Evans as VP, Investor Relations $94.54 / +13.72 (+16.98%)
08/04/22 Coinbase trading resumes 08/04/22 Coinbase trading halted, volatility trading pause 08/04/22 Coinbase jumps 34% to $108.46 after announcing partnership with BlackRock 08/04/22 Coinbase selected by BlackRock for crypto trading access 06/16/22 Cigna announces $3.5B accelerated stock repurchase agreements 06/07/22 FTC announces inquiry into pharmacy benefit managers 05/02/22 Bioventus agrees to nationwide contract with Cigna for DUROLANE, GELSYN-3 03/08/22 Kala Pharmaceuticals announces EYSUVIS now covered by UnitedHealthcare, Cigna $50.40 / +26.3 (+109.13%)
07/05/22 ChemoCentryx appoints Jennifer Herron to board of directors 06/06/22 ChemoCentryx reports safety results from Phase 1 trial of CCX559 07/18/22 BlackRock, QLS Advisors announce partnership 07/15/22 BlackRock reports Q2 total net inflows of $90B 08/04/22 BioCryst resumes enrollment in BCX9930 clinical program 08/04/22 BioCryst sees 2022 ORLADEYO revenue $255M-$265M 07/01/22 BioCryst presents new data on ORLADEYO 06/22/22 BioCryst announces ORLADEYO data to be presented at EEACI Hybrid Congress 2022 08/04/22 Alibaba CEO says 'we saw signs of recovery across our businesses in June' 07/29/22 SEC adds Alibaba, Mogo to list of companies facing possible delisting 07/29/22 SEC adds Alibaba to Holding Foreign Companies Accountable Act list 07/25/22 Alibaba pursues primary listing in Hong Kong 08/04/22 Amgen to acquire ChemoCentryx for $52 per share in cash, or EV of $3.7B 08/04/22 Amgen to acquire ChemoCentryx for $52 per share in cash 07/27/22 Ideaya Biosciences, Amgen enter IDE397 clinical trial collaboration 06/06/22 Amgen announces FDA approved RIABNI 08/04/22 Adtran sees Q3 non-GAAP gross margin 35.5%-38.5% 07/06/22 Adtran says FDI approvals completed for Adva Optical combination 07/06/22 Adva Optical announces approval of public exchange offer of Acorn HoldCo 05/05/22 Adtran sees Q2 non-GAAP gross margin 35%-37% 08/01/22 BofA Alibaba price target lowered to $155 from $162 at BofA 07/19/22 Bernstein Alibaba upgraded to Outperform from Market Perform at Bernstein 07/11/22 Goldman Sachs Pinduoduo grocery focus to drive sustained growth, says Goldman Sachs 07/11/22 Goldman Sachs Alibaba price target raised to $167 from $163 at Goldman Sachs $94.54 / +13.72 (+16.98%)
08/04/22 Mizuho Coinbase shares jumped 20% 'for no good reason,' says Mizuho 07/25/22 JPMorgan JPMorgan sees increased share dilution risk for Coinbase, Robinhood 07/14/22 DA Davidson Coinbase price target lowered to $90 from $135 at DA Davidson 07/14/22 Mizuho Coinbase price target lowered to $42 from $45 at Mizuho 07/18/22 Deutsche Bank BlackRock price target lowered to $720 from $725 at Deutsche Bank 07/13/22 Deutsche Bank BlackRock price target lowered to $725 from $747 at Deutsche Bank 07/11/22 UBS BlackRock price target lowered to $718 from $825 at UBS 07/08/22 JPMorgan BlackRock price target lowered to $729 from $902 at JPMorgan 08/04/22 Piper Sandler ChemoCentryx downgraded to Neutral from Overweight at Piper Sandler 06/07/22 Stifel Mirati Therapeutics price target raised to $111 from $105 at Stifel 06/01/22 Oppenheimer Amgen price target raised to $290 from $285 at Oppenheimer 05/27/22 Stifel Mirati Therapeutics after-hours move lower 'overdone,' says Stifel $50.40 / +26.3 (+109.13%)
08/04/22 Canaccord ChemoCentryx assumed with a Buy at Canaccord 03/02/22 Raymond James ChemoCentryx could beat consensus 'handily' in Q2, says Raymond James 03/02/22 Stifel ChemoCentryx's Q4 was positive-launch quarter, says Stifel 08/01/22 Jefferies Concert Pharmaceuticals price target raised to $14 from $9.50 at Jefferies 07/27/22 Benchmark AbCellera collaboration lowers reliance on Lilly, says Benchmark 07/18/22 Cowen Cowen believes Global Pharma quarterly results will be strong 07/08/22 Morgan Stanley Eli Lilly price target raised to $395 from $369 at Morgan Stanley 07/07/22 UBS Kellogg downgraded to Neutral from Buy at UBS 06/22/22 JPMorgan Kellogg breakup likely doesn't alter share valuation, says JPMorgan 06/22/22 Deutsche Bank Kellogg price target lowered to $72 from $74 at Deutsche Bank 06/22/22 Citi Kellogg price target raised to $87 from $83 at Citi GBT Global Blood Therapeutics $45.62 / +11.705 (+34.51%)
08/04/22 Truist Truist sees Novartis, Vertex as logical suitors for Global Blood 06/28/22 JPMorgan Global Blood Therapeutics price target lowered to $36 from $39 at JPMorgan 05/11/22 Wedbush Global Blood Therapeutics added to Best Ideas List at Wedbush 05/05/22 Oppenheimer Global Blood Therapeutics price target lowered to $71 from $86 at Oppenheimer 07/29/22 BofA Amazon price target bumped to $170 at BofA after 'mostly positive' quarter 07/28/22 DA Davidson Best Buy price target lowered to $88 from $110 at DA Davidson 07/28/22 Wells Fargo Best Buy price target lowered to $70 from $82 at Wells Fargo 07/27/22 Deutsche Bank Walmart price target lowered to $142 from $166 at Deutsche Bank 08/01/22 Goldman Sachs Bilibili received one China game approval for August, says Goldman Sachs 07/11/22 Goldman Sachs Tencent downgraded to Buy from Conviction Buy at Goldman Sachs 07/05/22 Macquarie China online gaming re-ratings 'about to begin,' says Macquarie 06/28/22 Investec Tencent downgraded to Sell from Hold at Investec 08/03/22 Tigress Financial Alphabet price target raised to $186 from $183 at Tigress Financial 07/27/22 Truist Chrome cookie phase-out delay positive for Criteo, says Truist 07/27/22 KeyBanc Google's cookie phase-out delay not surprising, says KeyBanc 07/27/22 RBC Capital Google cookie phase-out delay adds another year of uncertainty, says RBC Capital 05/05/22 Piper Sandler BioCryst price target lowered to $19 from $24 at Piper Sandler 04/18/22 Barclays BioCryst downgraded to Equal Weight from Overweight at Barclays 04/12/22 Piper Sandler BioCryst 39% selloff presents 'unique opportunity,' says Piper Sandler 04/11/22 BofA BioCryst downgraded to Neutral at BofA after PNH studies paused 05/10/22 R.F. Lafferty Lordstown Motors downgraded to Sell from Hold at R.F. Lafferty 05/10/22 Deutsche Bank Lordstown Motors price target lowered to $2 from $3 at Deutsche Bank 03/01/22 R.F. Lafferty Lordstown Motors price target lowered to $4 from $7 at R.F. Lafferty 03/01/22 Deutsche Bank Lordstown Motors price target lowered to $3 from $7 at Deutsche Bank 08/04/22 Canaccord Pacific Biosciences price target lowered to $14 from $17 at Canaccord 05/15/22 Piper Sandler Pacific Biosciences price target lowered to $6 from $13 at Piper Sandler 05/05/22 Cantor Fitzgerald Pacific Biosciences price target lowered to $19 from $23 at Cantor Fitzgerald 03/01/22 Piper Sandler Pacific Biosciences price target lowered to $13 from $20 at Piper Sandler 07/07/22 Citi Gannett price target lowered to $2.65 from $4.25 at Citi 06/15/22 CL King Ecovys, Innospec to benefit after EPA raises RFS to 15%, says CL King 03/23/22 BWS Financial Ecovyst initiated with a Buy at BWS Financial 03/02/22 Deutsche Bank Ecovyst price target lowered to $13 from $16 at Deutsche Bank 11/29/21 Citi Ecovyst initiated with a Neutral at Citi 08/02/22 Deutsche Bank Paramount price target lowered to $35 from $43 at Deutsche Bank 07/29/22 Barrington Paramount downgraded to Market Perform from Outperform at Barrington 07/27/22 Evercore ISI Paramount price target lowered to $28 from $36 at Evercore ISI 07/27/22 Evercore ISI Fox Corp. price target lowered to $38 from $44 at Evercore ISI 08/02/22 Citi Yeti transferred with Buy rating at Citi 08/01/22 Credit Suisse Yeti price target lowered to $80 from $95 at Credit Suisse 07/21/22 BTIG Yeti price target lowered to $87 from $93 at BTIG 07/21/22 Goldman Sachs Yeti price target lowered to $55 from $65 at Goldman Sachs 07/14/22 Jefferies Jefferies downgrades Cigna to Hold, views as most vulnerable MCO in downturn 07/14/22 Truist Cigna price target raised to $330 from $310 at Truist 07/14/22 Jefferies Cigna downgraded to Hold from Buy at Jefferies 07/05/22 Stifel Stifel says 'logical to assume' Walgreens could look at 1Life Healthcare 07/18/22 Morgan Stanley Restaurant Brands price target lowered to $52 from $56 at Morgan Stanley 07/11/22 Deutsche Bank Restaurant Brands price target lowered to $64 from $70 at Deutsche Bank 07/11/22 Piper Sandler Restaurant Brands price target lowered to $52 from $60 at Piper Sandler 06/09/22 Barclays Restaurant Brands price target lowered to $61 from $68 at Barclays 07/14/22 Needham Adtran initiated with a Buy at Needham 04/11/22 Rosenblatt Rosenblatt starts Adtran at Buy, sees strong demand for Fiber-to-the-Premise 04/11/22 Rosenblatt Adtran initiated with a Buy at Rosenblatt 02/23/22 Loop Capital Adtran initiated with a Hold at Loop Capital 08/04/22 Morgan Stanley Levi Strauss downgraded to Equal Weight from Overweight at Morgan Stanley 07/20/22 Stifel Levi Strauss price target lowered to $23 from $26 at Stifel 07/15/22 UBS Levi Strauss price target lowered to $24 from $31 at UBS 07/10/22 Morgan Stanley Levi Strauss price target lowered to $19 from $33 at Morgan Stanley 08/04/22 Canaccord Trupanion price target lowered to $90 from $100 at Canaccord 08/04/22 Northland Trupanion price target lowered to $70 from $80 at Northland 08/04/22 Piper Sandler Trupanion downgraded to Neutral from Overweight at Piper Sandler 05/27/22 Piper Sandler Trupanion price target lowered to $80 from $95 at Piper Sandler 08/04/22 Williams Trading Under Armour downgraded to Sell from Hold at Williams Trading 08/04/22 Barclays Under Armour price target lowered to $12 from $14 at Barclays 08/04/22 Baird Under Armour downgraded to Neutral at Baird amid uncertain macro environment 08/04/22 Baird Under Armour downgraded to Neutral from Outperform at Baird 08/04/22 UBS Southern Company upgraded to Buy from Neutral at UBS 07/21/22 Guggenheim Southern Company price target raised to $80 from $76 at Guggenheim 07/18/22 Barclays Southern Company price target lowered to $79 from $82 at Barclays 06/30/22 UBS Southern Company price target lowered to $76 from $83 at UBS 08/04/22 Goldman Sachs Paymentus downgraded to Neutral from Buy at Goldman Sachs 07/15/22 Baird Paymentus price target lowered to $20 from $26 at Baird 05/05/22 Citi Paymentus price target lowered to $25 from $35 at Citi 05/05/22 SMBC Nikko Paymentus price target lowered to $23 from $37 at SMBC Nikko 08/04/22 Yeti reports Q2 adjusted EPS 63c vs. 68c a year ago 05/11/22 Yeti raises FY22 adjusted EPS view to $2.86-$2.91 from $2.82-$2.86 07/25/22 Walmart lowers profit outlook for FY23, sees adjusted EPS to decline 10%-12% 07/25/22 Walmart lowers profit outlook for Q2, sees adjusted EPS to decline 8%-9% 07/25/22 Walmart lowers profit outlook for Q2 and FY23 05/17/22 Walmart cuts FY23 EPS view to flat from up 5%-6%, consensus $6.76 08/03/22 Under Armour sees Q2 EPS 15c-17c, consensus 26c 08/03/22 Under Armour lowers 2022 adjusted EPS view 47c-53c from 63c-68c 08/03/22 Under Armour reports Q1 adjusted EPS 3c, consensus 4c 08/02/22 Notable companies reporting before tomorrow's open 08/03/22 Trupanion reports Q2 EPS (33c), consensus (22c) 04/28/22 Trupanion reports Q1 EPS (22c), consensus (17c) 02/16/22 Trupanion reports Q4 EPS (17c), may not compare to consensus (95c) 07/28/22 Southern Company reports Q2 adjusted EPS $1.07, consensus 83c 04/28/22 Southern Company sees FY22 adjusted EPS $3.50-$3.60, consensus $3.55 04/28/22 Southern Company sees Q2 adjusted EPS 80c, consensus 83c 04/28/22 Southern Company reports Q1 adjusted EPS 97c, consensus 91c 08/04/22 Lordstown Motors reports Q2 EPS 32c, consensus (45c) 05/09/22 Lordstown Motors reports Q1 EPS (46c), consensus (46c) 08/04/22 Restaurant Brands reports Q2 EPS 76c, consensus 73c 05/03/22 Restaurant Brands reports Q1 adjusted EPS 64c, consensus 62c 02/15/22 Restaurant Brands reports Q4 EPS 74c, consensus 69c 02/14/22 Notable companies reporting before tomorrow's open 08/03/22 Paymentus sees FY22 revenue $485M-$492M, consensus $495.05M 08/03/22 Paymentus reports Q2 adjusted EPS 0c, consensus 1c 05/04/22 Paymentus sees FY22 revenue $492M-$497M, consensus $492.91M 05/04/22 Paymentus reports Q1 adjusted EPS 3c, consensus 1c 08/04/22 Paramount reports Q2 EPS 53c, consensus 62c 05/03/22 Paramount reports Q1 EPS 60c, consensus 51c 08/03/22 Pacific Biosciences now sees 2022 revenue $138M-$145M, consensus $161.95M 08/03/22 Pacific Biosciences reports Q2 non-GAAP EPS (34c), consensus (32c) 05/04/22 Pacific Biosciences reports Q1 EPS (37c), consensus (31c) 02/15/22 Pacific Biosciences reports Q4 EPS (30c), consensus (28c) 05/11/22 Ondas reports Q1 EPS (24c) vs. (12c) last year 03/22/22 Ondas reports 2021 EPS (44c) vs. (66c) last year 08/04/22 Eli Lilly cuts FY22 EPS view to $7.90-$8.05 from $8.15-$8.30, consensus $8.08 08/04/22 Eli Lilly reports Q2 EPS $1.25, consensus $1.68 07/07/22 Levi Strauss backs FY22 adjusted EPS view $1.50-$1.56, consensus $1.55 07/07/22 Levi Strauss reports Q2 adjusted EPS 29c, consensus 23c 06/01/22 Levi Strauss says 6%-8% annual net revenue growth target up from 4%-6% view 06/01/22 Levi Strauss backs FY22 adjusted EPS view of $1.50-$1.56, consensus $1.55 08/04/22 Kellogg raises FY22 EPS growth to 2% from 1%-2%, consensus $4.10 08/04/22 Kellogg reports Q2 EPS $1.23, consensus $1.05 07/26/22 Alphabet reports Q2 EPS $1.21, consensus $1.30 07/26/22 Notable companies reporting after market close 04/26/22 Alphabet reports Q1 EPS $24.62, consensus $25.96 04/26/22 Notable companies reporting after market close 08/04/22 Gannett reports 'challenging' Q2 results, cuts FY22 outlook 02/24/22 Gannett sees 2022 revenue $3.07B-$3.16B, consensus $3.11B 02/24/22 Gannett sees Q1 revenue $745M-$755M 02/24/22 Gannett reports Q4 EPS (17c), one estimate (1c) GBT Global Blood Therapeutics $45.62 / +11.705 (+34.51%)
05/04/22 Global Blood Therapeutics reports Q1 EPS ($1.26), consensus ($1.30) 02/24/22 Global Blood Therapeutics reports Q4 EPS ($1.36), consensus ($1.13) 07/29/22 Ecovyst raises FY22 revenue view to $830M-$850M from $810M-$830M 07/29/22 Ecovyst reports Q2 adjusted EPS 22c, consensus 18c 04/28/22 Ecovyst sees FY22 revenue $810M-$830M, consensus $738.89M 04/28/22 Ecovyst reports Q1 adjusted EPS 15c, consensus 14c $94.54 / +13.72 (+16.98%)
05/10/22 Coinbase reports Q1 EPS ($1.98) vs. $3.80 last year 05/10/22 Coinbase reports Q1 revenue $1.165B, consensus $1.48B 05/10/22 Notable companies reporting after market close 02/24/22 Coinbase reports Q4 adjusted EBITDA $1.21B vs. $288M y/y 08/04/22 Cigna raises FY22 adjusted EPS view to at least $22.90 from at least $22.60 08/04/22 Cigna reports Q2 adjusted EPS $6.22, consensus $5.48 $50.40 / +26.3 (+109.13%)
05/05/22 ChemoCentryx reports Q1 EPS (55c), consensus (30c) 03/01/22 ChemoCentryx reports Q4 EPS (58c), consensus (58c) 07/15/22 BlackRock reports Q2 adjusted EPS $7.36, consensus $7.90 07/14/22 Notable companies reporting before tomorrow's open 06/20/22 Fly Intel: Top five weekend stock stories 04/13/22 BlackRock reports Q1 adjusted EPS $9.52, consensus $8.84 08/04/22 BioCryst reports Q2 EPS (32c), consensus (34c) 05/05/22 BioCryst continues to see 2022 ORLADEYO revenue no less than $250M 05/05/22 BioCryst reports Q1 EPS (40c), consensus (37c) 02/23/22 BioCryst reports Q4 adjusted EPS (40c), consensus (30c) 08/04/22 Alibaba reports Q1 adjusted EPS $1.75, consensus $1.53 08/03/22 Notable companies reporting before tomorrow's open 05/26/22 Alibaba reports Q4 EPS $1.25, consensus $1.10 04/27/22 Amgen backs FY22 adjusted EPS view $17.00-$18.00, consensus $17.63 04/27/22 Amgen reports Q1 adjusted EPS $4.25, consensus $4.10 04/27/22 Notable companies reporting after market close 02/08/22 Amgen sees FY22 revenue $25.4B-$26.5B, consensus $27B 08/04/22 Adtran sees Q3 revenue $320M-$340M, including ADVA 08/03/22 Adtran reports Q2 EPS 19c, consensus 11c 05/05/22 Adtran sees Q2 revenue $165M-$175M, consensus $161.99M 05/04/22 Adtran reports Q1 EPS 20c, consensus 5c
On The Fly
Show Hide Related Items >> <<
07/28/22 User reports indicate problems at Zoom, Downdetector says 06/22/22 Zoom Video introduces Zoom One offering 06/06/22 Zoom Video announces Greg Tomb as president 06/06/22 Zoom Video, Genesys enter strategic agreement for Zoom Phone 08/03/22 Under Armour sees 'overabundance' of product hitting the market in 2022 08/03/22 Under Armour's Plank says Browne in running for permanent CEO job 08/03/22 Under Armour's Plank: Interim CEO Colin Browne has done 'outstanding' job 08/03/22 Under Armour focused on search for permanent CEO, says Plank 06/29/22 Eco Material Technologies announces agreement with Georgia Power 06/29/22 Georgia Power to launch landmark coal ash beneficial use project 04/19/22 Southern Company raises annual dividend by 8c per share to $2.72 per share 03/18/22 U.S. district court gives preliminary approval of Southern Company settlement 08/02/22 JetBlue beginning early work on Spirit integration planning, says CEO 08/02/22 Spirit deal 'turbocharges' strategic growth plans, says JetBlue CEO 08/02/22 JetBlue CEO 'pleased we found a path forward' with Spirit 07/28/22 JetBluee sees regulatory approval for Spirit Airlines deal no later than H1 2024 06/16/22 Revolve Group falls -9.6% 05/04/22 Revolve Group falls -23.7% 05/04/22 Revolve Group falls -15.9% 05/04/22 Revolve Group falls -14.8% 05/09/22 RingCentral names Sonalee Parekh CFO 03/23/22 Theta Lake attracts $50M in series B funding 02/22/22 RingCentral sees Q1 EPS 34c, consensus 33c 02/22/22 RingCentral reports Q4 subscriptions revenue up 37% y/y 08/03/22 Ping Identity rises 59.9% 08/03/22 Ping Identity rises 59.5% 08/03/22 Ping Identity rises 59.9% 08/03/22 Ping Identity to be acquired by Thoma Bravo for $2.8B or $28.50 per share 08/04/22 Paymentus falls -23.9% 08/04/22 Paymentus falls -19.7% 02/18/22 Paymentus falls -12.1% 02/17/22 Paymentus falls -20.4% 07/29/22 NatWest Group sees FY22 net income around GBP 12.5B 04/29/22 NatWest Group backs FY22 guidance 07/27/22 Lloyds Banking sees FY22 banking NIM above 280bps 04/27/22 Lloyds Banking now sees FY22 banking NIM above 270bps 02/24/22 Lloyds Banking sees FY22 banking NIM above 260bps 07/28/22 Kohl's becomes 'exclusive' wholesale retailer for Levi's SilverTab collection 07/21/22 Kohl's announces expansion of Kohl's Media Network 07/15/22 Kohl's Chief Technology and Supply Chain Officer, Paul Gaffney, to depart 07/07/22 Grove Collaborative expands retail footprint 08/02/22 JetBlue sees cost program delivering run-rate savings of $150M-$200M 08/02/22 JetBlue embarking on new plan to keep costs low, says president 08/02/22 JetBlue to move into new Terminal A at Newark Airport in Q4, says Geraghty 08/02/22 JetBlue to phase out E190 fleet by mid-2025 05/11/22 Five9 extends EMEA footprint with new data centers in Frankfurt and Amsterdam 04/21/22 Five9 enters strategic agreement with Deloitte Canada 06/30/22 Light & Wonder enters into amended purchase pact for sale of OpenBet to Endeavor 05/13/22 Endeavor Group rises 22.0% 05/13/22 Endeavor Group rises 21.3% 02/14/22 Third Point buys Rivian, exits Meta in Q4 07/06/22 Autohome falls -8.1% 05/24/22 Autohome reports Q1 EPS 14c, consensus 40c 05/06/22 Autohome appoints Craig Yan Zeng as CFO 08/04/22 BofA Autohome upgraded to Neutral at BofA amid auto market turnaround 08/04/22 BofA Autohome upgraded to Neutral from Underperform at BofA 07/13/22 Daiwa Autohome initiated with an Outperform at Daiwa 06/28/22 Citi Citi ups Autohome target to $41, opens 'positive catalyst watch' 08/04/22 UBS Southern Company upgraded to Buy from Neutral at UBS 07/21/22 Guggenheim Southern Company price target raised to $80 from $76 at Guggenheim 07/18/22 Barclays Southern Company price target lowered to $79 from $82 at Barclays 06/30/22 UBS Southern Company price target lowered to $76 from $83 at UBS 08/03/22 Citi America Movil upgraded to Buy from Neutral at Citi 06/01/22 Citi America Movil initiated with a Neutral at Citi 04/18/22 Barclays America Movil price target raised to $23 from $21 at Barclays 03/18/22 JPMorgan America Movil downgraded to Neutral from Overweight at JPMorgan 08/03/22 Goldman Sachs Lloyds Banking upgraded to Buy from Neutral at Goldman Sachs 07/29/22 Barclays Lloyds Banking price target raised to 55 GBp from 52 GBp at Barclays 07/29/22 Berenberg Lloyds Banking price target raised to 55 GBp from 52 GBp at Berenberg 07/29/22 Deutsche Bank Lloyds Banking price target raised to 64 GBp from 61 GBp at Deutsche Bank 08/03/22 Goldman Sachs NatWest Group upgraded to Conviction Buy from Buy at Goldman Sachs 08/03/22 Barclays NatWest Group price target raised to 400 GBp from 315 GBp at Barclays 08/03/22 AlphaValue/Baader NatWest Group upgraded to Reduce from Sell at AlphaValue/Baader 08/02/22 RBC Capital NatWest Group price target raised to 330 GBp from 250 GBp at RBC Capital 08/04/22 Cowen Kohl's downgraded to Market Perform on consumer pressure at Cowen 08/04/22 Cowen Kohl's downgraded to Market Perform from Outperform at Cowen 07/26/22 Deutsche Bank Walmart outlook 'red flag for apparel,' says Deutsche Bank 07/15/22 UBS Kohl's price target lowered to $20 from $32 at UBS 08/04/22 Williams Trading Under Armour downgraded to Sell from Hold at Williams Trading 08/04/22 Barclays Under Armour price target lowered to $12 from $14 at Barclays 08/04/22 Baird Under Armour downgraded to Neutral at Baird amid uncertain macro environment 08/04/22 Baird Under Armour downgraded to Neutral from Outperform at Baird 08/04/22 Wedbush Wedbush downgrades Revolve Group to Neutral, lowers price target to $23 08/04/22 Cowen Revolve Group price target lowered to $32 from $52 at Cowen 08/04/22 BTIG Revolve Group price target lowered to $31 from $50 at BTIG 08/04/22 BMO Capital Revolve Group price target lowered to $22 from $29 at BMO Capital 08/04/22 DA Davidson Ping Identity downgraded to Neutral from Buy at DA Davidson 08/04/22 Stephens Ping Identity downgraded to Equal Weight from Overweight at Stephens 08/04/22 Barclays Ping Identity downgraded to Equal Weight from Overweight at Barclays 08/04/22 BTIG Ping Identity downgraded to Neutral from Buy at BTIG 08/04/22 Goldman Sachs Paymentus downgraded to Neutral from Buy at Goldman Sachs 07/15/22 Baird Paymentus price target lowered to $20 from $26 at Baird 05/05/22 Citi Paymentus price target lowered to $25 from $35 at Citi 05/05/22 SMBC Nikko Paymentus price target lowered to $23 from $37 at SMBC Nikko 08/04/22 MKM Partners Zoom Video initiated with a Buy at MKM Partners 08/03/22 Craig-Hallum RingCentral price target lowered to $110 from $175 at Craig-Hallum 07/19/22 Bernstein Zoom Video initiated with a Market Perform at Bernstein 07/13/22 Piper Sandler Zoom Video price target raised to $115 from $96 at Piper Sandler 08/04/22 MKM Partners RingCentral initiated with a Buy at MKM Partners 08/03/22 Northland RingCentral price target lowered to $75 from $175 at Northland 08/03/22 Truist RingCentral price target lowered to $80 from $120 at Truist 08/04/22 BofA JetBlue resumed with a Neutral at BofA 08/02/22 BofA Frontier Group resumed with a Buy at BofA 07/29/22 Cowen Spirit Airlines downgraded to Market Perform from Outperform at Cowen 07/29/22 JPMorgan Spirit Airlines downgraded to Underweight from Overweight at JPMorgan 08/04/22 BofA BofA starts 'well positioned' Endeavor Group at Buy 08/04/22 BofA Endeavor Group initiated with a Buy at BofA 08/02/22 Deutsche Bank Endeavor Group price target lowered to $36 from $40 at Deutsche Bank 07/27/22 Evercore ISI Endeavor Group price target lowered to $30 from $35 at Evercore ISI 08/04/22 MKM Partners Five9 initiated with a Buy at MKM Partners 07/25/22 UBS Five9 price target lowered to $135 from $180 at UBS 07/13/22 Piper Sandler Five9 price target lowered to $150 from $166 at Piper Sandler 07/11/22 Canaccord Five9 upside to estimates with market share gains possible, says Canaccord 08/03/22 Deutsche Bank JetBlue price target lowered to $10 from $16 at Deutsche Bank 06/20/22 Fly Intel: Top five weekend stock stories 05/23/22 Zoom Video raises FY23 EPS view to $3.70-$3.77 from $3.45-$3.51 05/23/22 Zoom Video sees Q2 EPS 90-92c, consensus 88c 05/23/22 Zoom Video reports Q1 EPS $1.03, consensus 87c 08/03/22 Under Armour sees Q2 EPS 15c-17c, consensus 26c 08/03/22 Under Armour lowers 2022 adjusted EPS view 47c-53c from 63c-68c 08/03/22 Under Armour reports Q1 adjusted EPS 3c, consensus 4c 08/02/22 Notable companies reporting before tomorrow's open 07/28/22 Southern Company reports Q2 adjusted EPS $1.07, consensus 83c 04/28/22 Southern Company sees FY22 adjusted EPS $3.50-$3.60, consensus $3.55 04/28/22 Southern Company sees Q2 adjusted EPS 80c, consensus 83c 04/28/22 Southern Company reports Q1 adjusted EPS 97c, consensus 91c 05/04/22 Spirit Airlines sees FY22 other capital expenditures $240M 05/04/22 Spirit Airlines sees Q2 adjusted operating expenses $1.355B-$1.365B 05/04/22 Spirit Airlines reports Q1 adjusted EPS ($1.60), consensus ($1.58) 08/03/22 Revolve Group reports Q2 EPS 22c, consensus 31c 08/03/22 Notable companies reporting after market close 05/03/22 Revolve Group reports Q1 EPS 30c, consensus 27c 02/23/22 Revolve Group sees FY22 revenue up at least 20%, consensus $1.07B 08/02/22 RingCentral raises FY22 adjusted EPS view to $1.91-$1.95 from $1.83-$1.87 08/02/22 RingCentral sees Q3 adjusted EPS 50c-51c, consensus 48c 08/02/22 RingCentral reports Q2 adjusted EPS 45c, consensus 40c 08/02/22 Notable companies reporting after market close 08/03/22 Ping Identity reports Q2 adjusted EPS (34c), consensus (11c) 05/04/22 Ping Identity sees 2022 revenue $332M-$342M, consensus $334.91M 05/04/22 Ping Identity sees Q2 revenue $70M-$75M, consensus $73.58M 08/03/22 Paymentus sees FY22 revenue $485M-$492M, consensus $495.05M 08/03/22 Paymentus reports Q2 adjusted EPS 0c, consensus 1c 05/04/22 Paymentus sees FY22 revenue $492M-$497M, consensus $492.91M 05/04/22 Paymentus reports Q1 adjusted EPS 3c, consensus 1c 07/29/22 NatWest Group reports 1H attributable profit GBP 1.89B, RoTE 13.1% 04/29/22 NatWest reports Q1 operating profit before tax GBP1.25B vs. GBP885M last year 02/18/22 NatWest Group reports FY21 operating profit EUR 4B 07/27/22 Lloyds Banking reports 1H EPS 3.7p vs. 5.1p last year 04/27/22 Lloyds Banking reports Q1 EPS 1.5p vs. 1.8p last year 02/24/22 Lloyds Banking reports FY21 EPS 7.5% vs. 1.2p last year 07/01/22 Kohl's cuts Q2 sales view to down high-single digits from down low-single digits 05/19/22 Kohl's cuts FY22 adjusted EPS view to $6.45-$6.85 from $7.00-$7.50 05/19/22 Kohl's reports Q1 adjusted EPS 11c, consensus 70c 05/18/22 Notable companies reporting before tomorrow's open 08/02/22 JetBlue reports Q2 EPS (47), consensus (11c) 08/01/22 Notable companies reporting before tomorrow's open 07/28/22 Five9 raises FY22 EPS view to $1.38-$1.40 from $1.22-$1.24, consensus $1.22 07/28/22 Five9 sees Q3 adjusted EPS 31c-33c, consensus 30c 07/28/22 Five9 reports Q2 adjusted EPS 34c, consensus 18c 04/28/22 Five9 sees FY22 EPS $1.22-$1.24, consensus $1.13 05/12/22 Endeavor Group raises FY22 revenue view to $5.235B-$5.475B from $5.2B-$5.45B 05/12/22 Endeavor Group reports Q1 EPS $1.16, consensus 42c 03/16/22 Endeavor sees FY22 revenue $5.2B-$5.45B, consensus $5.11B 03/16/22 Endeavor reports Q4 EPS (7c), consensus 17c 08/03/22 Autohome reports Q2 adjusted EPS 56c, consensus 54c 02/24/22 Autohome reports Q4 EPS 58c, consensus 55c
Downgrade
Williams Trading analyst…
Williams Trading analyst Sam Poser downgraded Under Armour to Sell from Hold with a $7 price target.
Show Hide Related Items >> <<
08/03/22 Under Armour sees 'overabundance' of product hitting the market in 2022 08/03/22 Under Armour's Plank says Browne in running for permanent CEO job 08/03/22 Under Armour's Plank: Interim CEO Colin Browne has done 'outstanding' job 08/03/22 Under Armour focused on search for permanent CEO, says Plank 08/04/22 Barclays Under Armour price target lowered to $12 from $14 at Barclays 08/04/22 Baird Under Armour downgraded to Neutral at Baird amid uncertain macro environment 08/04/22 Baird Under Armour downgraded to Neutral from Outperform at Baird 08/01/22 Deutsche Bank Under Armour price target lowered to $13 from $21 at Deutsche Bank 08/03/22 Under Armour sees Q2 EPS 15c-17c, consensus 26c 08/03/22 Under Armour lowers 2022 adjusted EPS view 47c-53c from 63c-68c 08/03/22 Under Armour reports Q1 adjusted EPS 3c, consensus 4c 08/02/22 Notable companies reporting before tomorrow's open 07/29/22 Under Armour pays $67.5M to settle UCLA lawsuit, LA Times says 05/28/22 Under Armour transformation will take much longer to play out, Barron's says 04/23/22 Under Armour stock could be 'a slam dunk,' Barron's says 04/04/22 Itochu to buy majority stake in Under Armour's Japan distributor, Nikkei says 08/03/22 Fly Intel: Pre-market Movers 07/29/22 What You Missed On Wall Street On Friday 07/29/22 What You Missed On Wall Street This Morning 07/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/03/22 Unusually active option classes on open August 3rd 06/30/22 Under Armour Class A put volume heavy and directionally bearish 06/29/22 Under Armour Class A put volume heavy and directionally bearish 05/24/22 Under Armour Class A put volume heavy and directionally bearish 04/05/22 Unusually active option classes on open April 5th 03/14/22 Under Armour call volume above normal and directionally bullish 02/23/22 Under Armour call volume above normal and directionally bullish 02/22/22 Under Armour call volume above normal and directionally bullish
Recommendations
Barclays analyst Adrienne…
Barclays analyst Adrienne Yih lowered the firm's price target on Under Armour to $12 from $14 and keeps an Overweight rating on the shares. The company's fiscal Q1 earnings and outlook were better than feared, with the sales outlook intact despite the increased promotional backdrop and margin pressure, Yih tells investors in a research note.
Show Hide Related Items >> <<
08/03/22 Under Armour sees 'overabundance' of product hitting the market in 2022 08/03/22 Under Armour's Plank says Browne in running for permanent CEO job 08/03/22 Under Armour's Plank: Interim CEO Colin Browne has done 'outstanding' job 08/03/22 Under Armour focused on search for permanent CEO, says Plank 08/04/22 Baird Under Armour downgraded to Neutral at Baird amid uncertain macro environment 08/04/22 Baird Under Armour downgraded to Neutral from Outperform at Baird 08/01/22 Deutsche Bank Under Armour price target lowered to $13 from $21 at Deutsche Bank 07/25/22 Piper Sandler Under Armour assumed with a Neutral at Piper Sandler 08/03/22 Under Armour sees Q2 EPS 15c-17c, consensus 26c 08/03/22 Under Armour lowers 2022 adjusted EPS view 47c-53c from 63c-68c 08/03/22 Under Armour reports Q1 adjusted EPS 3c, consensus 4c 08/02/22 Notable companies reporting before tomorrow's open 07/29/22 Under Armour pays $67.5M to settle UCLA lawsuit, LA Times says 05/28/22 Under Armour transformation will take much longer to play out, Barron's says 04/23/22 Under Armour stock could be 'a slam dunk,' Barron's says 04/04/22 Itochu to buy majority stake in Under Armour's Japan distributor, Nikkei says 08/03/22 Fly Intel: Pre-market Movers 07/29/22 What You Missed On Wall Street On Friday 07/29/22 What You Missed On Wall Street This Morning 07/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/03/22 Unusually active option classes on open August 3rd 06/30/22 Under Armour Class A put volume heavy and directionally bearish 06/29/22 Under Armour Class A put volume heavy and directionally bearish 05/24/22 Under Armour Class A put volume heavy and directionally bearish 04/05/22 Unusually active option classes on open April 5th 03/14/22 Under Armour call volume above normal and directionally bullish 02/23/22 Under Armour call volume above normal and directionally bullish 02/22/22 Under Armour call volume above normal and directionally bullish
Downgrade
As previously reported,…
As previously reported, Baird analyst Jonathan Komp downgraded Under Armour to Neutral from Outperform with a price target of $10, down from $12. Despite Q1 results that were "relatively in-line," some "pockets of weakness" and a much lower FY23 margin outlook are materially weighing on current earnings visibility, said Komp. He believes Under Armour can achieve higher profitability over the longer-term under the right leadership, but he sees heightened FY23 and FY24 earnings risk amid an uncertain macroeconomic environment, said Komp, who lowered his FY23 and FY24 earnings expectations.
Show Hide Related Items >> <<
08/03/22 Under Armour sees 'overabundance' of product hitting the market in 2022 08/03/22 Under Armour's Plank says Browne in running for permanent CEO job 08/03/22 Under Armour's Plank: Interim CEO Colin Browne has done 'outstanding' job 08/03/22 Under Armour focused on search for permanent CEO, says Plank 08/04/22 Baird Under Armour downgraded to Neutral from Outperform at Baird 08/01/22 Deutsche Bank Under Armour price target lowered to $13 from $21 at Deutsche Bank 07/25/22 Piper Sandler Under Armour assumed with a Neutral at Piper Sandler 07/20/22 Stifel Under Armour price target lowered to $10 from $13 at Stifel 08/03/22 Under Armour sees Q2 EPS 15c-17c, consensus 26c 08/03/22 Under Armour lowers 2022 adjusted EPS view 47c-53c from 63c-68c 08/03/22 Under Armour reports Q1 adjusted EPS 3c, consensus 4c 08/02/22 Notable companies reporting before tomorrow's open 07/29/22 Under Armour pays $67.5M to settle UCLA lawsuit, LA Times says 05/28/22 Under Armour transformation will take much longer to play out, Barron's says 04/23/22 Under Armour stock could be 'a slam dunk,' Barron's says 04/04/22 Itochu to buy majority stake in Under Armour's Japan distributor, Nikkei says 08/03/22 Fly Intel: Pre-market Movers 07/29/22 What You Missed On Wall Street On Friday 07/29/22 What You Missed On Wall Street This Morning 07/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/03/22 Unusually active option classes on open August 3rd 06/30/22 Under Armour Class A put volume heavy and directionally bearish 06/29/22 Under Armour Class A put volume heavy and directionally bearish 05/24/22 Under Armour Class A put volume heavy and directionally bearish 04/05/22 Unusually active option classes on open April 5th 03/14/22 Under Armour call volume above normal and directionally bullish 02/23/22 Under Armour call volume above normal and directionally bullish 02/22/22 Under Armour call volume above normal and directionally bullish
Downgrade
Baird analyst Jonathan…
Baird analyst Jonathan Komp downgraded Under Armour to Neutral from Outperform with a price target of $10, down from $12.
Show Hide Related Items >> <<
08/03/22 Under Armour sees 'overabundance' of product hitting the market in 2022 08/03/22 Under Armour's Plank says Browne in running for permanent CEO job 08/03/22 Under Armour's Plank: Interim CEO Colin Browne has done 'outstanding' job 08/03/22 Under Armour focused on search for permanent CEO, says Plank 08/01/22 Deutsche Bank Under Armour price target lowered to $13 from $21 at Deutsche Bank 07/25/22 Piper Sandler Under Armour assumed with a Neutral at Piper Sandler 07/20/22 Stifel Under Armour price target lowered to $10 from $13 at Stifel 07/15/22 UBS Under Armour price target lowered to $12 from $18 at UBS 07/11/22 Jefferies Jefferies downgrades Under Armour to Hold, halves price target to $10 08/03/22 Under Armour sees Q2 EPS 15c-17c, consensus 26c 08/03/22 Under Armour lowers 2022 adjusted EPS view 47c-53c from 63c-68c 08/03/22 Under Armour reports Q1 adjusted EPS 3c, consensus 4c 08/02/22 Notable companies reporting before tomorrow's open 07/29/22 Under Armour pays $67.5M to settle UCLA lawsuit, LA Times says 05/28/22 Under Armour transformation will take much longer to play out, Barron's says 04/23/22 Under Armour stock could be 'a slam dunk,' Barron's says 04/04/22 Itochu to buy majority stake in Under Armour's Japan distributor, Nikkei says 08/03/22 Fly Intel: Pre-market Movers 07/29/22 What You Missed On Wall Street On Friday 07/29/22 What You Missed On Wall Street This Morning 07/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/03/22 Unusually active option classes on open August 3rd 06/30/22 Under Armour Class A put volume heavy and directionally bearish 06/29/22 Under Armour Class A put volume heavy and directionally bearish 05/24/22 Under Armour Class A put volume heavy and directionally bearish 04/05/22 Unusually active option classes on open April 5th 03/14/22 Under Armour call volume above normal and directionally bullish 02/23/22 Under Armour call volume above normal and directionally bullish 02/22/22 Under Armour call volume above normal and directionally bullish
Options
Unusual total active…
Unusual total active option classes on open include: Eargo (EAR), ETFS Silver Trust (SIVR), Applied DNA Sciences (APDN), Under Armour Class A (UAA), fuboTV (FUBO), Senseonics (SENS), Ford (F), CVS Health (CVS), Moderna (MRNA), and HP Inc. (HPQ).
Show Hide Related Items >> <<
08/03/22 Under Armour sees 'overabundance' of product hitting the market in 2022 08/03/22 Under Armour's Plank says Browne in running for permanent CEO job 08/03/22 Under Armour's Plank: Interim CEO Colin Browne has done 'outstanding' job 08/03/22 Under Armour focused on search for permanent CEO, says Plank 08/03/22 Senseonics announces positive coverage decision for Eversense E3 CGM from Anthem 06/16/22 Senseonics announces CE Mark approval of Eversense E3 CGM System 04/06/22 Senseonics announces first patient implanted with Eversense E3 02/14/22 Senseonics receives FDA approval for Eversense E3 CGM system 08/03/22 Moderna sees FY22 CapEx $600M-$800M 08/03/22 Moderna backs advance purchase agreements for expected delivery in 2022 of $21B 08/03/22 Moderna announces new $3B share repurchase plan 07/29/22 Moderna enters contract with U.S. government for 66M COVID-19 booster doses 07/19/22 HP Inc. announces early participation results of exchange offer 07/19/22 HP Inc. introduces HP LaserJet Managed E800/E700 series 07/13/22 HP Inc. announces further extension of exchange offer for Plantronics notes 07/12/22 HP Inc. announces amendment, extension of exchange offer 07/21/22 FOX Nation expands distribution to FuboTV 07/14/22 Crackle, Popcornflix FAST channels launch on FuboTV 06/23/22 FuboTV hopes for 'fair and reasonable price' in negotiations with Univision 06/02/22 FuboTV expands distribution of four UEFA matches to PPV in June 08/03/22 Ford reports July U.S. sales up 36.6% y/y to 163,942 vehicles 07/27/22 Ford says semiconductors still an issue 07/27/22 Ford says operations are too complex 07/27/22 Ford says increasing dividend to 15c per share 06/27/22 Eargo announces up to $125M strategic investment from Patient Square Capital 05/31/22 Nasdaq confirms continued listing of Eargo stock 05/13/22 Eargo receives Nasdaq non-compliance letter 04/29/22 Eargo sees Q1 gross systems shipped 5,770 08/03/22 CVS Health says liquidity, cash position 'remain excellent' 08/03/22 CVS Health says posted strong results across all business segments in Q2 08/03/22 CVS Health raises FY guidance for total pharmacy claims processed to 2.29B-2.32B 07/28/22 New York Attorney General sues CVS Health over antitrust laws APDN Applied DNA Sciences 08/02/22 Applied DNA begins validation of PCR-based monkeypox virus test 06/21/22 US guidance permits DNA traceability, isotopic testing as evidence under UFLPA 06/06/22 Applied DNA Sciences, EvviVax announce publication of LinearDNA data 03/14/22 Applied DNA in LOI with Spindle for LinearDNATM research collaboration 09/23/21 Fly Intel: Top five analyst downgrades 09/23/21 William Blair William Blair downgrades Eargo on 'multiple unknowns' from criminal probe 09/23/21 Wells Fargo Wells Fargo cuts Eargo to Equal Weight, slashes price target $10 from $52 09/23/21 William Blair Eargo downgraded to Market Perform from Outperform at William Blair APDN Applied DNA Sciences 05/16/22 H.C. Wainwright Applied DNA Sciences price target lowered to $4 from $6 at H.C. Wainwright 02/14/22 Maxim Applied DNA Sciences price target lowered to $6 from $18 at Maxim 02/11/22 H.C. Wainwright Applied DNA Sciences price target lowered to $6 from $8 at H.C. Wainwright 12/10/21 H.C. Wainwright Applied DNA Sciences price target lowered to $8 from $11 at H.C. Wainwright 08/01/22 Deutsche Bank Under Armour price target lowered to $13 from $21 at Deutsche Bank 07/25/22 Piper Sandler Under Armour assumed with a Neutral at Piper Sandler 07/20/22 Stifel Under Armour price target lowered to $10 from $13 at Stifel 07/15/22 UBS Under Armour price target lowered to $12 from $18 at UBS 06/17/22 Stephens FuboTV sports selection dealt a blow by Apple deal with MLS, says Stephens 05/06/22 Needham FuboTV price target lowered to $5 from $15 at Needham 05/06/22 Evercore ISI FuboTV price target lowered to $7 from $20 at Evercore ISI 05/06/22 JPMorgan FuboTV downgraded to Underweight from Neutral at JPMorgan 07/25/22 H.C. Wainwright Senseonics price target lowered to $3 from $6 at H.C. Wainwright 02/11/22 Craig-Hallum Senseonics halved sales outlook despite FDA approval, says Craig-Hallum 08/19/21 H.C. Wainwright Senseonics initiated with a Buy at H.C. Wainwright 08/02/22 Citi Citi ticks up Ford target, closes 'Upside Catalyst Watch' 08/01/22 Benchmark Ford price target lowered to $23 from $25 at Benchmark 07/28/22 Deutsche Bank Ford price target raised to $13 from $12 at Deutsche Bank 07/26/22 JPMorgan Ford price target lowered to $19 from $21 at JPMorgan 07/21/22 Stifel Logical to see Oak Street, Cano as 'in play' after 1Life deal, says Stifel 07/15/22 Evercore ISI CVS Health, Coupa added to 'Best SMID Core Ideas' list at Evercore ISI 07/11/22 Evercore ISI Evercore downgrades 1Life Healthcare to In Line on valuation after jump 07/07/22 BTIG 1Life Healthcare upgraded to Buy from Neutral at BTIG 06/29/22 Evercore ISI Icosavax upgraded to Outperform at Evercore on 'competitive' RSV vaccine data 06/14/22 Piper Sandler Piper Sandler confident in positive VRBPAC opinion for Moderna's SpikeVax 06/13/22 Morgan Stanley Moderna pediatric EUA vaccine briefing docs 'clean,' says Morgan Stanley 05/17/22 Piper Sandler Moderna price target lowered to $214 from $348 at Piper Sandler 07/14/22 JPMorgan HP Inc. price target lowered to $36 from $39 at JPMorgan 07/05/22 Evercore ISI HP downgraded to In Line at Evercore on fears of 'more severe' PC headwinds 07/05/22 Evercore ISI HP Inc. downgraded to In Line from Outperform at Evercore ISI 06/02/22 Evercore ISI HP Inc. removed from 'Tactical Outperform' list at Evercore ISI 08/03/22 Under Armour sees Q2 EPS 15c-17c, consensus 26c 08/03/22 Under Armour lowers 2022 adjusted EPS view 47c-53c from 63c-68c 08/03/22 Under Armour reports Q1 adjusted EPS 3c, consensus 4c 08/02/22 Notable companies reporting before tomorrow's open 05/10/22 Senseonics backs FY22 revenue view of $14M-$18M, consensus $16.2M 05/10/22 Senseonics reports Q1 EPS 19c, consensus (3c) 03/01/22 Senseonics reports Q4 EPS 19c, consensus (3c) 02/11/22 Senseonics sees Q4 revenue $4M, consensus $3.91M 08/03/22 Moderna reports Q2 GAAP EPS $5.24, consensus $4.55 05/04/22 Moderna reports Q1 GAAP EPS $8.58, consensus $5.21 05/03/22 Notable companies reporting before tomorrow's open 05/31/22 HP Inc. raises FY22 EPS view to $4.24-$4.38 from $4.18-$4.38, consensus $4.25 05/31/22 HP Inc. sees Q3 EPS $1.03-$1.08, consensus $1.02 05/31/22 HP Inc. reports Q2 EPS $1.08, consensus $1.05 05/31/22 Notable companies reporting after market close 05/05/22 FuboTV reports Q1 EPS (69c), consensus (65c) 05/05/22 Notable companies reporting after market close 02/23/22 FuboTV reports Q4 EPS (57c), consensus (67c) 02/23/22 Notable companies reporting after market close 07/27/22 Ford reports Q2 adjusted EPS 68c, consensus 45c 07/27/22 Notable companies reporting after market close 06/28/22 InterDigital raises Q2 revenue view to $120M-$124M from $114M-$120M 04/27/22 Ford reports Q1 adjusted EPS 38c, consensus 37c 08/03/22 CVS Health raises FY22 revenue view to $307B-$312B from $305B-$310B 08/03/22 CVS Health raises 2022 adjusted EPS view $8.40-$8.60 from $8.20-$8.40 08/03/22 CVS Health reports Q2 adjusted EPS $2.40, consensus $2.17 APDN Applied DNA Sciences 05/12/22 Applied DNA Sciences reports Q2 EPS (23c), consensus (33c) 02/10/22 Applied DNA Sciences reports Q1 EPS (63c), consensus (27c) 07/29/22 Under Armour pays $67.5M to settle UCLA lawsuit, LA Times says 05/28/22 Under Armour transformation will take much longer to play out, Barron's says 04/23/22 Under Armour stock could be 'a slam dunk,' Barron's says 04/04/22 Itochu to buy majority stake in Under Armour's Japan distributor, Nikkei says 06/28/22 FDA panel recommends omicron update for COVID vaccine boosters, CNBC says 06/23/22 Moderna vaccine for kids gets backing of CDC advisers, WSJ reports 06/15/22 Moderna to study COVID vaccine in babies as young as 3 months, WSJ says 06/02/22 Pfizer ask FDA to authorize three doses of vaccine for kids under 5, WSJ report 06/06/22 CFOs send letter to Treasury Secretary on foreign tax credit rules, WSJ reports 04/23/22 Merck, CVS among dividend stocks to help whip inflation now, Barron's says 04/09/22 HP stock gets a Buffett boost, still 'a screaming buy,' Barron's says 03/30/22 TSMC says demand for consumer electronics starting to slow, Nikkei Asia reports 07/26/22 NHTSA investigating over 1.8M Stellantis, Ford, GM vehicles, Reuters reports 07/26/22 NHTSA probes Ford Bronco over reports of engine failure, WSJ reports 07/20/22 Ford intends to cut as many as 8,000 positions in coming weeks, Bloomberg says 07/20/22 Ford intends to cut as many as 8,000 positions in coming weeks, Bloomberg says 07/05/22 1Life Healthcare weighs options after drawing takeover interest, Bloomberg says 07/05/22 1Life Healthcare weighs options after drawing takeover interest, Bloomberg says 06/27/22 CVS, Walmart rationing Plan B pills amid demand surge, WSJ reports 05/25/22 CVS to stop filling controlled substance prescriptions for Cerebral, WSJ reports 08/03/22 Fly Intel: Pre-market Movers 07/29/22 What You Missed On Wall Street On Friday 07/29/22 What You Missed On Wall Street This Morning 07/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/11/22 Wall Street in Fives - Must Read Lists for Friday 02/11/22 Wall Street in Fives - Must Read Lists at Midday 07/11/22 What You Missed On Wall Street On Monday 07/11/22 What You Missed On Wall Street This Morning 06/29/22 What You Missed On Wall Street On Wednesday 06/29/22 What You Missed On Wall Street This Morning 07/11/22 Fly Insider: Karuna Therapeutics, HP among weeks notable insider trades 07/05/22 What You Missed On Wall Street On Tuesday 07/05/22 What You Missed On Wall Street This Morning 07/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/13/22 Short Report: Upstart shorts take profits as stock craters on guidance cut 05/06/22 What You Missed On Wall Street On Friday 05/06/22 What You Missed On Wall Street This Morning 05/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/28/22 What You Missed On Wall Street On Thursday 07/28/22 What You Missed On Wall Street This Morning 07/28/22 Fly Intel: Pre-market Movers 07/27/22 Fly Intel: After-Hours Movers 06/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/09/22 What You Missed On Wall Street On Thursday 06/09/22 What You Missed On Wall Street This Morning 06/30/22 Under Armour Class A put volume heavy and directionally bearish 06/29/22 Under Armour Class A put volume heavy and directionally bearish 05/24/22 Under Armour Class A put volume heavy and directionally bearish 05/19/22 Under Armour Class A put volume heavy and directionally bearish 05/10/22 Senseonics options imply 17.6% move in share price post-earnings 04/19/22 Largest borrow rate increases among liquid names 03/23/22 Largest borrow rate increases among liquid names 03/18/22 Largest borrow rate increases among liquid names 07/14/22 Moderna put volume heavy and directionally bearish 07/08/22 Early notable gainers among liquid option names on July 8th 07/08/22 Unusually active option classes on open July 8th 07/05/22 Moderna call volume above normal and directionally bullish 07/11/22 HP Inc. put volume heavy and directionally bearish 05/31/22 HP Inc. options imply 7.2% move in share price post-earnings 05/27/22 Early notable gainers among liquid option names on May 27th 05/24/22 HP Inc. put volume heavy and directionally bearish 07/15/22 Largest borrow rate increases among liquid names 04/04/22 fuboTV call volume above normal and directionally bullish 03/29/22 fuboTV call volume above normal and directionally bullish 03/16/22 fuboTV call volume above normal and directionally bullish 08/02/22 Notable open interest changes for August 2nd 08/01/22 Ford call volume above normal and directionally bullish 08/01/22 Notable open interest changes for August 1st 07/27/22 Ford options imply 5.6% move in share price post-earnings 03/07/22 Eargo options imply 12.6% move in share price post-earnings 02/10/22 Eargo options imply 10.7% move in share price post-earnings 02/03/22 Eargo options imply 9.5% move in share price post-earnings 07/14/22 CVS Health call volume above normal and directionally bullish 06/02/22 CVS Health put volume heavy and directionally bearish 05/04/22 Unusually active option classes on open May 4th 05/02/22 Unusually active option classes on open May 2nd
Hot Stocks
Show Hide Related Items >> <<
08/03/22 Under Armour's Plank says Browne in running for permanent CEO job 08/03/22 Under Armour's Plank: Interim CEO Colin Browne has done 'outstanding' job 08/03/22 Under Armour focused on search for permanent CEO, says Plank 08/03/22 Under Armour sees selecting permanent CEO by end of year 08/01/22 Deutsche Bank Under Armour price target lowered to $13 from $21 at Deutsche Bank 07/25/22 Piper Sandler Under Armour assumed with a Neutral at Piper Sandler 07/20/22 Stifel Under Armour price target lowered to $10 from $13 at Stifel 07/11/22 Jefferies Jefferies downgrades Under Armour to Hold, halves price target to $10 07/15/22 UBS Under Armour price target lowered to $12 from $18 at UBS 08/03/22 Under Armour sees Q2 EPS 15c-17c, consensus 26c 08/03/22 Under Armour lowers 2022 adjusted EPS view 47c-53c from 63c-68c 08/03/22 Under Armour reports Q1 adjusted EPS 3c, consensus 4c 08/02/22 Notable companies reporting before tomorrow's open 07/29/22 Under Armour pays $67.5M to settle UCLA lawsuit, LA Times says 05/28/22 Under Armour transformation will take much longer to play out, Barron's says 04/23/22 Under Armour stock could be 'a slam dunk,' Barron's says 04/04/22 Itochu to buy majority stake in Under Armour's Japan distributor, Nikkei says 08/03/22 Fly Intel: Pre-market Movers 07/29/22 What You Missed On Wall Street On Friday 07/29/22 What You Missed On Wall Street This Morning 07/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/30/22 Under Armour Class A put volume heavy and directionally bearish 06/29/22 Under Armour Class A put volume heavy and directionally bearish 05/24/22 Under Armour Class A put volume heavy and directionally bearish 05/19/22 Under Armour Class A put volume heavy and directionally bearish 04/05/22 Unusually active option classes on open April 5th 03/14/22 Under Armour call volume above normal and directionally bullish 02/23/22 Under Armour call volume above normal and directionally bullish 02/22/22 Under Armour call volume above normal and directionally bullish
Earnings
Sees Q2 operating income…
Sees Q2 operating income $105M-$115M.
Show Hide Related Items >> <<
08/03/22 Under Armour's Plank says Browne in running for permanent CEO job 08/03/22 Under Armour's Plank: Interim CEO Colin Browne has done 'outstanding' job 08/03/22 Under Armour focused on search for permanent CEO, says Plank 08/03/22 Under Armour sees selecting permanent CEO by end of year 08/01/22 Deutsche Bank Under Armour price target lowered to $13 from $21 at Deutsche Bank 07/25/22 Piper Sandler Under Armour assumed with a Neutral at Piper Sandler 07/20/22 Stifel Under Armour price target lowered to $10 from $13 at Stifel 07/11/22 Jefferies Jefferies downgrades Under Armour to Hold, halves price target to $10 07/15/22 UBS Under Armour price target lowered to $12 from $18 at UBS 08/03/22 Under Armour lowers 2022 adjusted EPS view 47c-53c from 63c-68c 08/03/22 Under Armour reports Q1 adjusted EPS 3c, consensus 4c 08/02/22 Notable companies reporting before tomorrow's open 07/29/22 Under Armour pays $67.5M to settle UCLA lawsuit, LA Times says 05/28/22 Under Armour transformation will take much longer to play out, Barron's says 04/23/22 Under Armour stock could be 'a slam dunk,' Barron's says 04/04/22 Itochu to buy majority stake in Under Armour's Japan distributor, Nikkei says 08/03/22 Fly Intel: Pre-market Movers 07/29/22 What You Missed On Wall Street On Friday 07/29/22 What You Missed On Wall Street This Morning 07/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/30/22 Under Armour Class A put volume heavy and directionally bearish 06/29/22 Under Armour Class A put volume heavy and directionally bearish 05/24/22 Under Armour Class A put volume heavy and directionally bearish 05/19/22 Under Armour Class A put volume heavy and directionally bearish 04/05/22 Unusually active option classes on open April 5th 03/14/22 Under Armour call volume above normal and directionally bullish 02/23/22 Under Armour call volume above normal and directionally bullish 02/22/22 Under Armour call volume above normal and directionally bullish
